TTNNF yields 0.78% · JNJ yields 2.13%● Live data
📍 TTNNF pulled ahead of the other in Year 1
Combined, TTNNF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TTNNF + JNJ for your $10,000?
Toho Titanium Co., Ltd. manufactures and sells titanium metals, catalysts for propylene polymerization, and electronic materials in Japan. It offers titanium metals, such as titanium sponge, titanium ingots, titanium powder, and titanium products. The company also provides propylene polymerization catalysts for producing polypropylene. In addition, it offers electronic materials, including titanium dioxide for use in multi-layered ceramic capacitors (MLCC), positive temperature coefficient thermistors, dielectric filters, and piezo injector products, as well as an additive for optical lenses, and medicines and food; and ultra-fine nickel powder for use as an internal electrodes of MLCCs. Further, the company offers chemicals, such as titanium tetrachloride for the manufacture of titanium sponge, high purity titanium dioxide, barium titanate, polymerization catalyst, and titanium tetrachloride aqueous solutions; titanium tetrachloride aqueous solutions for use in cosmetics, pigments, and barium titanate applications; and potassium titanates. Additionally, it provides lanthanum lithium titanate ceramics for next generation battery application; and WEBTi, a porous titanium sheet for use in filter, electrode, noise absorber, and photocatalyst applications. The company was incorporated in 1948 and is headquartered in Chigasaki, Japan.
Full TTNNF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.